Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
Kathryn Arbour
Eileen M. O'Reilly, MD
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
María-Victoria Mateos, MD, PhD
Switching Strategies: Switch or Stay—What’s Your Call?
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Treat-to-Target: Are We There Yet?
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
Case Review: Targets Are Met—Can You Stick the Landing?
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
Remission: Can You Prove It?
Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
Severity Assessment: Can You Pin the Stage on the Patient?
Tailoring Treatment: Can You Select the Best Therapy?
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Cristina Rodriguez, MD
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Linda Stein Gold, MD
Bruce Strober, MD, PhD
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
All Sides of the Joint: Integrated TGCT Care Across Specialties
IBD Immunopathogenesis: Do You Know What You're Blocking?
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
RSV in Infants and Young Children: Are You Taking It Seriously Enough?
Tina Q. Tan, MD
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
April W. Armstrong, MD, MPH
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Kathleen Moore, MD, MS
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.